Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The HIV-1 envelope glycoprotein V3 glycan supersite is a major site of vulnerability located at the base of the third variable (V3) loop of the gp120 subunit. It is characterized by a dense cluster of high-mannose glycans, most notably the N332 glycan, and a highly conserved underlying peptide motif known as GDIR (residues 324-327). This supersite is a primary target for several potent broadly neutralizing antibodies (bNAbs) that penetrate the viral glycan shield to bind both the carbohydrate and protein components. Biologically, this region is essential for viral entry as it facilitates the interaction between the HIV-1 envelope and host cell co-receptors, such as CCR5 or CXCR4. Therapeutic interventions, including passive immunization with bNAbs, target this site to neutralize the virus and prevent infection. However, the site is subject to therapeutic challenges such as viral escape through glycan shifting or mutations within the GDIR motif that confer resistance to specific antibodies.
Broadly neutralizing antibodies bind to the V3 glycan supersite, specifically interacting with the N332 glycan and the conserved GDIR peptide motif, which sterically hinders the envelope glycoprotein from interacting with host co-receptors (CCR5 or CXCR4), thereby blocking viral entry and membrane fusion.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HIV-1 envelope glycoprotein V3 glycan supersite (GDIR motif) (V3 glycan supersite).